Cargando…

The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis

BACKGROUND: Several clinical trials have evaluated the efficacy and safety of interleukin-13 (IL-13) with lebrikizumab and tralokinumab in patients with moderate to severe atopic dermatitis (AD). However, the safety and efficacy of IL-13 inhibitors as a potent biologic for AD remain elusive. OBJECTI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Jing, Danrong, Cheng, Jun, Chen, Xiang, Shen, Minxue, Liu, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364267/ https://www.ncbi.nlm.nih.gov/pubmed/35967348 http://dx.doi.org/10.3389/fimmu.2022.923362

Ejemplares similares

Selective IL-13 inhibitors for the treatment of atopic dermatitis
por: Gonçalves, Francisca, et al.
Publicado: (2021)

Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
por: Liang, Junqin, et al.
Publicado: (2022)

Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Huang, Ruixue, et al.
Publicado: (2017)

Associations of second-hand smoke exposure with hand eczema and atopic dermatitis among college students in China
por: Jing, Danrong, et al.
Publicado: (2020)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

Efficacy and Safety of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
por: Li, Chenyang, et al.
Publicado: (2022)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
por: Iznardo, Helena, et al.
Publicado: (2023)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Le, Michelle, et al.
Publicado: (2021)

Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
por: Sans-de San Nicolàs, Lídia, et al.
Publicado: (2023)

Management of atopic dermatitis: safety and efficacy of phototherapy
por: Patrizi, Annalisa, et al.
Publicado: (2015)

New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration
por: Qi, Hong-jiao, et al.
Publicado: (2021)

The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
por: Pappa, Georgia, et al.
Publicado: (2022)

Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials
por: £abędź, Natalia, et al.
Publicado: (2019)

Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm Syndrome
por: Kawakami, Toshiaki, et al.
Publicado: (2015)

Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis
por: Chen, Qianyu, et al.
Publicado: (2023)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

Toll-like receptors: their roles in pathomechanisms of atopic dermatitis
por: Tamagawa-Mineoka, Risa
Publicado: (2023)

Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis
por: SEDEH, Farnam B., et al.
Publicado: (2022)

Comparison of Efficacy of Anti-interleukin-17 in the Treatment of Psoriasis Between Caucasians and Asians: A Systematic Review and Meta-Analysis
por: Zhang, Danyi, et al.
Publicado: (2022)

Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
por: Alves, Carlos, et al.
Publicado: (2023)

Neonatal-derived IL-17 producing dermal γδ T cells are required to prevent spontaneous atopic dermatitis
por: Spidale, Nicholas A, et al.
Publicado: (2020)

Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
por: Li, Ling, et al.
Publicado: (2023)

Association of Periodontitis and Atopic Dermatitis with the Levels of IL-13, IL-31, and TSLP in the Gingival Crevicular Fluid
por: Jiménez, Constanza, et al.
Publicado: (2023)

IL-37 Ameliorating Allergic Inflammation in Atopic Dermatitis Through Regulating Microbiota and AMPK-mTOR Signaling Pathway-Modulated Autophagy Mechanism
por: Hou, Tianheng, et al.
Publicado: (2020)

The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
por: Bashrahil, Bader, et al.
Publicado: (2023)

Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
por: Zhao, Dan-Jie, et al.
Publicado: (2023)

Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis
por: Hulshof, Lies, et al.
Publicado: (2018)

Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
por: Humeau, Mélanie, et al.
Publicado: (2022)

Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis
por: Joshi, Aaroh Anand, et al.
Publicado: (2023)

Applications of single-cell RNA sequencing in atopic dermatitis and psoriasis
por: Xia, Dengmei, et al.
Publicado: (2022)

T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis
por: Zheng, Chunjiao, et al.
Publicado: (2023)

Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis
por: Xue, Xiali, et al.
Publicado: (2023)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021)

The methylation profile of IL4, IL5, IL10, IFNG and FOXP3 associated with environmental exposures differed between Polish infants with the food allergy and/or atopic dermatitis and without the disease
por: Gorzkiewicz, Marta, et al.
Publicado: (2023)

Targeting IL-4 for the Treatment of Atopic Dermatitis
por: Chiricozzi, Andrea, et al.
Publicado: (2020)

Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3
por: Su, Wenxing, et al.
Publicado: (2022)

Safety Profile and Tolerability of Topical Phosphodiesterase 4 Inhibitors for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
por: Martín-Santiago, Ana, et al.
Publicado: (2022)

Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021)

Atopic dermatitis: Is innate or adaptive immunity in control? A clinical perspective
por: Ong, Peck Y.
Publicado: (2022)

Integrated metabolomics and lipidomics study of patients with atopic dermatitis in response to dupilumab
por: Zhang, Lishan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k7tgk0ub46ta1aj9mh8i4sefc9